We are live on
!
Find out more
DLA
Douglas Lane & Associates Portfolio holdings
AUM
$7.37B
1-Year Est. Return
21.9%
This Fund
S&P 500
This Quarter
Est. Return
-6.17%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.41B
AUM Growth
-$477M
(-8.1%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-0.45%
Top 10 Holdings %
Top 10 Hldgs %
20.51%
Holding
224
New
4
Increased
63
Reduced
129
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Haleon
HLN
|
+$15.6M |
| 2 |
GE Aerospace
GE
|
+$11.2M |
| 3 |
Charter Communications
CHTR
|
+$8.1M |
| 4 |
AB InBev
BUD
|
+$6.87M |
| 5 |
GSK
GSK
|
+$4.52M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Mills
GIS
|
+$22.5M |
| 2 |
Ulta Beauty
ULTA
|
+$10.5M |
| 3 |
Constellation Brands
STZ
|
+$5.05M |
| 4 |
Chubb
CB
|
+$4.88M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$4.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.03% |
| 2 | Healthcare | 15.64% |
| 3 | Technology | 15.46% |
| 4 | Industrials | 8.41% |
| 5 | Consumer Discretionary | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CSX Corp
CSX
$93.1B
| $228K | ﹤0.01% |
8,549
-582
| -6% | -$18.1K |
|
202
Brown-Forman Class B
BF.B
$13.1B
| $225K | ﹤0.01% |
3,375
| – | – |
|
203
Canadian Pacific Kansas City
CP
$80.5B
| $225K | ﹤0.01% |
3,378
| – | – |
|
204
Blackrock
BLK
$176B
| $219K | ﹤0.01% |
398
| – | – |
|
205
DuPont de Nemours
DD
$19.2B
| $217K | ﹤0.01% |
3,438
-427
| -11% | -$30.5K |
|
206
Hubbell
HUBB
$27.2B
| $212K | ﹤0.01% |
+950
| New | +$199K |
|
207
Medtronic
MDT
$112B
| $206K | ﹤0.01% |
2,557
-54
| -2% | -$4.85K |
|
208
Generac Holdings
GNRC
$12.5B
| $200K | ﹤0.01% |
1,123
-5
| -0.4% | -$1.15K |
|
|
ZIMV
209
DELISTED
ZimVie
ZIMV
| $192K | ﹤0.01% |
19,454
-8,303
| -30% | -$134K |
|
210
Transact Technologies
TACT
$58.6M
| $44K | ﹤0.01% |
12,081
-1,900
| -14% | -$8.25K |
|
|
LQMT
211
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
| $1K | ﹤0.01% |
10,000
| – | – |
|
212
Baxter International
BAX
$14.2B
| – | – |
-3,186
| Closed | -$205K |
|
213
L3Harris
LHX
$53.4B
| – | – |
-841
| Closed | -$203K |
|
214
Linde
LIN
$226B
| – | – |
-766
| Closed | -$220K |
|
215
Monster Beverage
MNST
$88.5B
| – | – |
-4,400
| Closed | -$204K |
|
216
Sony
SONY
$138B
| – | – |
-12,790
| Closed | -$209K |
|
|
RDUS
217
DELISTED
Radius Health, Inc.
RDUS
| – | – |
-10,000
| Closed | -$104K |
|
|
AHR
218
DELISTED
ANTHRACITE CAP INC
AHR
| – | – |
-13,772
| Closed | – |
|
Similar funds
GJL
DKCM
KWM
GLF
JF
YAM
ASN
DS
Douglas Lane & Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Douglas Lane & Associates held 224 positions worth $5.41B, down 8.1% from $5.89B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Douglas Lane & Associates's Q3 2022 filing shows 4 new, 63 increased, 129 reduced and 8 closed positions. Its largest new stake was Haleon: 2,404,664 shares worth $14.6M. The largest sale was General Mills, an estimated $22.5M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
- Douglas Lane & Associates's largest Q3 2022 buy was Haleon: 2,404,664 shares worth $14.6M.
- Douglas Lane & Associates added most to GE Aerospace in Q3 2022, an estimated $11.2M increase.
- Douglas Lane & Associates's biggest Q3 2022 reduction was General Mills, cutting an estimated $22.5M.
- Douglas Lane & Associates fully exited Linde in Q3 2022, selling an estimated $220K.
- Douglas Lane & Associates's ten largest holdings make up 21% of its $5.41B portfolio in Q3 2022.
- Douglas Lane & Associates opened 4 new positions and closed 8 in Q3 2022.
- Douglas Lane & Associates's portfolio value fell 8.1% quarter-over-quarter to $5.41B.
Based on Douglas Lane & Associates's 13F filing for Q3 2022, filed 14 Oct 2022.